Salus Discovery

Founded in 2019 and based in San Diego, Salus Discovery is a private, pre-revenue company focused on revolutionizing molecular diagnostics through innovative sample preparation technologies. Its core platforms, Flow and ESP, enable passive concentration and purification of analytes from complex samples, aiming to enhance the sensitivity of lateral flow assays (LFAs) and streamline workflows. The company targets significant unmet needs in point-of-care and laboratory diagnostics by making sensitive testing more accessible, affordable, and sustainable.

Flow: Passive analyte concentration technology for ~100x sensitivity boost in lateral flow assays (LFAs). ESP: A family of technologies for ultra-fast, simple extraction, concentration, and purification of analytes (cells, proteins, nucleic acids) from complex samples without sample loss.

Salus competes in the sample preparation and diagnostic sensitivity enhancement market against established life science tools companies (e.g., Qiagen, Bio-Rad, Danaher) and numerous startups developing microfluidic and novel concentration methods. Its differentiation lies in a focus on passive, materials-based simplicity and direct integration with existing LFA formats.